Japan Society of Clinical Chemistry

Message from JSCC President

Soon two years will have passed since I became President of JSCC and I would like to thank you all for your continuing support.

Last December, Prof. Yukio Ando made the arrangements for the 56th Annual Meeting of the Japan Society of Clinical Chemistry to be held in Kumamoto. A major objective was to support reconstruction following the Kumamoto Earthquake that occurred last April. The meeting was very rich in academic, technical and educational content, and was very well attended. It was a great pleasure to see that the participants were so satisfied with the program. I am very grateful to Prof. Ando, Prof. Matsui, Dr. Ikeda, Dr. Shinriki, and the staff of Kumamoto University hospital for their contributions to the meeting’s success.

JSCC has contributed greatly to the standardization of clinical laboratory testing, which is being promoted on a global level by IFCC. Just before the Kumamoto meeting, the APFCB Congress had been held in Taiwan and during it, JSCC had organized a symposium on standardization and harmonization in Japan. There were also symposia on standardization and harmonization arranged by member organizations of IFCC and APFCB from various countries. I felt that the standardization and harmonization of clinical laboratory testing are now absolutely essential if we are to provide truly scientific medical care.

IFCC has various committees that are very active internationally and we continually recommend JSCC members for them. We see this as an opportunity to gain good ideas from other committee members and share ideas that work well in Japan with them.

A report on the project to change the ALP activity measurement method from the JSCC consensus method to the IFCC method has been prepared by Prof. Yamadate, and approved by JSCC directors. As the next step, we will collaborate with JCCLS, JACRI and other clinical laboratory-related societies in achieving a change to a method that meets the consensus of all. In this regard, JCCLS, JACRI and JSCC concluded a comprehensive collaborative contract last September with the assistance of the Judicial and Ethical Affairs Committee. This should guarantee transparency in the content of projects and accelerate their progress.

It is no exaggeration to say that clinical chemistry is fundamental to controlling the quality of laboratory results. In order to ensure that clinical chemistry provides accurate laboratory results for use in medical care, good quality control and management of individual data are essential. In this regard, we have already operated the “Certified Clinical Chemistry and Immunochemistry Quality Assurance Medical Technologist” qualification system together with JAMT, and the “Certified Clinical Chemistry and Immunochemistry Quality Assurance Professional” qualification system has just been inaugurated. The latest system is mainly for professionals working in R&D at educational institutions and companies. We hope that many professionals will be interested in these systems and take their certification examinations.

Last year, we established the Committee on Pitfall Research and its activities have been progressing smoothly. Those of the Publications Committee, Public Relations Committee, and Future Directions Committee are also going well. Membership is steadily increasing. I am convinced that this is the result of excellent cooperation among directors, committees and company members, and would like to express my appreciation to them all.

The major events of this year are our board meeting in March (for the change of directors that takes place every two years), the general meeting of JSCC members (Tokyo) in June, IFCC-EFLM EuroMedLab (Athens) in June, our annual meeting (Prof. Hitoshi Chiba, Sapporo) in October, and the IFCC WorldLab (Durban) in October. I hope that many professionals in the field will register for these events and submit papers, and look forward to meeting you all in Sapporo, at other meetings in Japan or those held in other countries.

Finally, I would like to inform you that I will continue my efforts to promote the realization of JSCC’s mission of “Developing Innovative Scientific Clinical Chemistry and Laboratory Medicine Techniques”

I would be very grateful for your continuing cooperation in these efforts.

Masato Maekawa, MD, PhD
President, Japan Society of Clinical Chemistry

Profile of Japan Society of Clinical Chemistry

About Us

Clinical chemistry is an academic discipline that sees practical application in the clinical setting. In addition to forming the basis of services providing chemical analysis results for medical care in the daily clinical setting, it aids the elucidation of disease etiologies and pathologies and contributes to treatment and prevention. Thus, having various academic and practical aspects and including both analytical chemistry and clinical medicine, clinical chemistry is very wide ranging, and there is much interaction with other academic disciplines. Therefore, it does not only involve researchers in university and other research institutions but also those in various research laboratories such as those in hospitals and individual clinical departments, and industry research institutions.

Our Goals

The Japan Society of Clinical Chemistry was established for the purpose of promoting advances in clinical chemistry and related areas. Giving full consideration to research in the various specialized areas that constitute clinical chemistry, we aim to achieve information sharing that will bring about further organic integration so that, together, we can make an even greater contribution to medical care and medical science. In this regard, we established the company membership system in fiscal 2006 to strengthen cooperation with industry.

Fundamental Activities

The members of the Japanese Society of Clinical Chemistry engage in close cooperation in order to achieve an understanding of each other’s specialist areas and exchange ideas covering a wide range of clinical chemistry aspects. We are also active in holding events such as annual scientific meetings, and issue an academic journal titled Clinical Chemistry. The Society also has various technical committees and project teams that are involved in multidisciplinary and specialized research. In addition, we have nine branches nationwide to promote activities at the local level.

International Activities

The Japan Society of Clinical Chemistry is a member of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the Asia Pacific Federation of Clinical Biochemistry (APFCB). In addition, we continually engage in activities on an international level together with the International Union of Pure and Applied Chemistry - Clinical Chemistry Div (IUPAC - CCD) and the International Union of Biochemistry and Molecular Biology (IUBMB). In 2002, the 18th International Congress of Clinical Chemistry and Laboratory Medicine (ICCC) was held in Kyoto.

Our History

The Japan Society of Clinical Chemistry has a history of over 50 years, which began with the holding of the first "Medicinal Chemistry Symposium" in 1961. However, our history actually goes back a little further to the holding of the first "Clinical Chemistry Analysis Discourse Meeting" a voluntary meeting of a study group in Tokyo in 1957. This was expanded to become a nationwide activity through the holding of summer and winter seminars. The name of the academic meeting was changed from “Medical Chemistry Symposium” to “Clinical Chemistry Symposium” in 1971. This organization later joined forces with the “Japan Clinical Chemistry Study Group, which was established for the publication of our journal, titled "Clinical Chemistry". The Japan Society of Clinical Chemistry was formed though the merging of the “Clinical Chemistry Analysis Discourse Meeting”, “Clinical Chemistry Symposium” and “Japan Clinical Chemistry Study Group”, in 1981.

JSCC History(PDF)



Address: 5-8-10-605,Sendagaya,Shibuya-ku,Tokyo 151-0051 Japan
TEL: +81-3-3354-2006
FAX: +81-3-3354-2017